Clinical Trial Update: Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update evaluates the safety and efficacy of PolyHeme, a hemoglobin-based oxygen carrier, for hemorrhagic shock following traumatic i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Shock

Drugs mentioned

• PolyHeme (polyhemoglobin-based oxygen carrier)

Snippet

Sponsor: Northfield Laboratories | Conditions: Hemorrhagic Shock | Phase 3 | Status: UNKNOWN